US claims cohort (Shah et al., 2015, n≈1.4M)<0.5%
~1,400,920 circumcisions, all ages (US insurance claims data)
Total adverse events under 0.5%; serious AEs ~0.0008%–0.07%. Crucially, AE rates 10–20× higher when done AFTER infancy (ages 1–9) than neonatally — directly relevant where boys are cut older (e.g. PH tuli at ~8–12).
[104]WHO VMMC programmes (regulated)~1–3 / 100,000
Voluntary medical male circumcision, ages 10–14, trained providers
Severe adverse events on the order of 1–3 per 100,000 — but ONLY with trained providers, quality assurance and informed consent. The benchmark for what safe, supervised provision looks like; the opposite end from informal provision.
[105]WHO complication briefs (VMMC)32 fistula · 8/12 tetanus deaths
Cases reported to WHO, 2014–2018
WHO logged 32 urethral-fistula cases (2014–2018) and, in one tetanus consultation, 8 deaths among 12 associated cases. Illustrative of rare-but-severe harms in unhygienic settings — not a national rate.
[66]Provider setting — Turkey & Kenya series85% vs 2.6% · 35% vs 17%
Traditional vs physician providers
One Turkish series found 85% complications with traditional providers vs 2.6% with physicians; a Kenyan one 35% vs 17%. Provider setting dominates outcomes — the pattern behind warnings about informal practitioners everywhere.
[66]AAP policy (2012)Benefits “not great enough”
American Academy of Pediatrics task force
Benefits said to outweigh risks but “not great enough” to recommend routine circumcision — leaving the decision to families. The reference point invoked on both sides of the consent/necessity debate.
[93]US neonatal circumcision (correlational deaths)200 / 9.83M (10 yrs)
Inpatient neonatal circumcisions, 2001–2010
200 early deaths over ten years among 9.83 million inpatient neonatal circumcisions — explicitly correlational, NOT causal. A measured counterpoint to higher litigation-cited estimates.
[91]